Last Updated : May 5, 2020
Details
Project Status:
Completed
Project Line:
Health Technology Review
Project Sub Line:
Environmental Scan
Project Number:
ES0351-000
Canada's Drug Agency conducted an Environmental Scan to better understand the similarities and differences in the current public drug programs criteria for accessing biologic drugs in the treatment of rheumatoid arthritis (RA) in Canada.
The specific objective was to identify and to compare existing criteria for reimbursing biologic drugs in RA across Canadian public formularies.
The findings of this Environmental Scan support a broader policy question regarding the harmonization of public coverage policies for biologics in Canada for patients with RA.
Files
Comparative Assessment of Coverage Criteria for Biologic Disease-Modifying Antirheumatic Drugs Across Canadian Public Drug Plans: An Environmental Scan
Environmental Scan
PUBLISHED: August 2020
Last Updated : May 5, 2020